In vivo virtual biopsy: an AI-based imaging approach for classification of mutational status in NSCLC.
Datos básicos
Documentos
- No hay documentos
Participantes
Grupos
Financiadores - Promotores
QUIBIM SL
Cita
In vivo virtual biopsy: an AI-based imaging approach for classification of mutational status in NSCLC. (2022-NSCLC-01). QUIBIM SL. 2023IP:FRANCISCO DE ASÍS APARISI APARISI.
Portal de investigación